China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
News
Advanced Life Sciences: Addressing Antibiotic Resistance in Infectious Disease Market
The company’s lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.
Protected: Amarantus BioSciences Management Video
There is no excerpt because this is a protected post.
FINAL HOURS before Price Increase at Health 2.0 Fall Conference, San Francisco, Oct. 7-8!
There’s no better time to register to attend the Health 2.0 Fall Conference, being held October 7-8 at the Hilton San Francisco.
Protected: Opexa Management Interview
There is no excerpt because this is a protected post.
A Unique Roadblock for Pfizer’s Osteoarthritis Drug
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
Bone Fractures Expected to Contribute to Growth of Orthopedic Implant Market
Minnesota-based orthopedics startup Dgimed Ortho is seeking to raise $2 million for its bone-fracture system.
Medtech Start-Ups/Innovators Partner with Top Investors & Corporate Acquisition Leaders at IN3 Summit
October 27-29, 2010 • Grand Hyatt Hotel • San Francisco, CA
Researchers, Healthcare Companies Seek to Give COPD Patients Some Breathing Room
Breathing is one of the most basic human functions, but for an estimated 12 million people in the United States, the simple act of drawing a breath can be difficult and even painful.
A Busy Week for Multiple Sclerosis News
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.